Skip to main content
. 2014 Dec 5;6(3):325–333. doi: 10.1111/jdi.12298

Table 10.

Difference of metabolic factors before and after ezetimibe treatments for the reduction of homeostasis model assessment of insulin resistance

Metabolic factors HOMA-IR at baseline HOMA-IR at 24 weeks P-value
Hypertension (= 57) 2.10 2.11 0.879
Dyslipidemia (= 37) 2.46 2.33 0.556
Diabetes mellitus (= 21) 4.04 3.42 0.622

HOMA-IR, homeostasis model assessment of insulin resistance.